Mark Daniel Sabin, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 630 E 1400 N Ste 135, Logan, UT 84341 Phone: 435-787-8146 |
Brian Gardner Hadfield, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Stewart Hill Dr, Logan, UT 84321 Phone: 435-363-5430 |
News Archive
Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2009, as well as guidance for net sales and earnings per share (EPS) for the first quarter and full year 2010.
Part of the previously planned $7.5 billion U.S. aid package for Pakistan will be redirected to flood rebuilding projects, said USAID Administrator Rajiv Shah, the Associated Press reports. Shah also "warned that other nations would only contribute money if Islamabad could ensure it would be well spent."
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
A transplant biopsy system that uses gene chips to read molecules is far safer and more effective than existing approaches used for heart transplant biopsies and is showing promising results for lung transplant biopsies, new University of Alberta-led research shows.
Lexicon Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted its request for Orphan Drug designation for telotristat etiprate (LX1032) for the treatment of carcinoid syndrome.
› Verified 7 days ago